NYSE:NVST

Envista (NVST) Stock Price, News & Analysis

Envista logo
$24.06 -0.43 (-1.77%)
Closing price 03:59 PM Eastern
Extended Trading
$23.61 -0.45 (-1.87%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Envista Stock (NYSE:NVST)

Advanced

Key Stats

Today's Range
$23.89
▼
$24.97
50-Day Range
$22.65
▼
$27.21
52-Week Range
$18.77
▼
$30.42
Volume
2.33 million shs
Average Volume
2.94 million shs
Market Capitalization
$3.86 billion
P/E Ratio
6.22
Dividend Yield
N/A
Price Target
$29.00
Consensus Rating
Hold

Company Overview

Envista Holdings Corporation is a dental products and technology company that develops and supplies tools and services for dental professionals. Its offerings span implant dentistry, orthodontics, digital imaging, restorative care and other clinical applications.

The company’s products include dental implants and related treatment systems, orthodontic brackets and clear aligners, imaging equipment and software, and restorative and endodontic materials. Its brands include Nobel Biocare, Ormco, DEXIS, Kerr and KaVo.

Envista was formed in 2019 through the separation of Danaher Corporation’s dental businesses. It serves dental practices and laboratories in markets around the world.

AI Generated. May Contain Errors.

Envista Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
76th Percentile Overall Score

NVST MarketRank™: 
3.812930577635 of 5 stars

Envista scored higher than 76% of companies evaluated by MarketBeat, and ranked 152nd out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Envista has received a consensus rating of Hold. The company's average rating score is 2.35, and is based on no strong buy ratings, 6 buy ratings, 11 hold ratings, and no sell ratings.

  • Upside Potential

    Envista has a consensus price target of $29.00, representing about 20.5% upside from its current price of $24.06.

  • Amount of Analyst Coverage

    Envista has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Envista's stock forecast and price target.
  • Earnings Growth

    Earnings for Envista are expected to grow by 6.41% in the coming year, from $1.56 to $1.66 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Envista is 6.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.15.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Envista is 6.22, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.34.

  • Price to Earnings Growth Ratio

    Envista has a PEG Ratio of 1.16. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Envista has a P/B Ratio of 1.27. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Envista's valuation and earnings.
  • Percentage of Shares Shorted

    6.13% of the float of Envista has been sold short.
  • Short Interest Ratio / Days to Cover

    Envista has a short interest ratio ("days to cover") of 2.95, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Envista has recently decreased by 0.47%, indicating that investor sentiment is improving.
  • Dividend Yield

    Envista does not currently pay a dividend.

  • Dividend Growth

    Envista does not have a long track record of dividend growth.

  • News Sentiment

    Envista has a news sentiment score of 0.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Envista this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for NVST on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Envista to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Envista insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $220,000.00 in company stock.

  • Percentage Held by Insiders

    0.99% of the stock of Envista is held by insiders.

  • Percentage Held by Institutions

    Envista has minimal institutional ownership at this time.

  • Read more about Envista's insider trading history.
Receive NVST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Envista and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NVST Stock News Headlines

Envista Announces Pricing of $430 Million of Senior Notes
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.tc pixel
Envista (NYSE:NVST) Price Target Raised to $29.00
Envista (NYSE:NVST) Stock Gets Downgrade from Wall Street Zen
See More Headlines

NVST Stock Analysis - Frequently Asked Questions

Envista's stock was trading at $21.72 at the beginning of the year. Since then, NVST shares have increased by 10.8% and is now trading at $24.0570.

Envista Holdings Corporation (NYSE:NVST) issued its quarterly earnings results on Wednesday, November, 4th. The company reported $0.40 earnings per share for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The firm's revenue was up 3.2% compared to the same quarter last year.
Read the conference call transcript
.

Envista (NVST) raised $602 million in an initial public offering on Wednesday, September 18th 2019. The company issued 26,768,000 shares at $21.00-$24.00 per share. J.P. Morgan, Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and Baird, Evercore ISI, Jefferies, BofA Merrill Lynch, Credit Suisse, Stifel and William Blair were co-managers.

Top institutional shareholders of Envista include Boston Partners (0.91%), Royce & Associates LP (0.80%), Pzena Investment Management LLC (0.71%) and Ieq Capital LLC (0.28%). Insiders that own company stock include Eric Conley, Mischa Reis and Eric D Hammes.
View institutional ownership trends
.

Shares of NVST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Envista investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Enphase Energy (ENPH), NIO (NIO), Advanced Micro Devices (AMD), DraftKings (DKNG) and Electronic Arts (EA).

Company Calendar

Last Earnings
11/04/2026
Today
11/16/2026
Fiscal Year End
12/31/2026
Next Earnings (Estimated)
2/04/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NYSE:NVST
CIK
1757073
Employees
12,000
Year Founded
2018

Price Target and Rating

High Price Target
$33.00
Low Price Target
$23.00
Potential Upside/Downside
+20.5%
Consensus Rating
Hold
Rating Score (0-4)
2.35
Research Coverage
17 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.87
Trailing P/E Ratio
6.22
Forward P/E Ratio
14.49
P/E Growth
1.16
Net Income
$47 million
Net Margins
22.01%
Pretax Margin
23.78%
Return on Equity
8.26%
Return on Assets
4.54%

Debt

Debt-to-Equity Ratio
0.46
Current Ratio
2.45
Quick Ratio
2.10

Sales & Book Value

Annual Sales
$2.88 billion
Price / Sales
1.34
Cash Flow
$2.13 per share
Price / Cash Flow
11.28
Book Value
$18.89 per share
Price / Book
1.27

Miscellaneous

Outstanding Shares
160,345,000
Free Float
158,758,000
Market Cap
$3.86 billion
Optionable
Optionable
Beta
0.94

Social Links

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

This page (NYSE:NVST) was last updated on 11/16/2026 by MarketBeat.com Staff.
From Our Partners